These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27029038)

  • 1. Current perspectives between metabolic syndrome and cancer.
    Micucci C; Valli D; Matacchione G; Catalano A
    Oncotarget; 2016 Jun; 7(25):38959-38972. PubMed ID: 27029038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
    Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
    Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine and immune disequilibrium as a probable link between metabolic syndrome and carcinogenesis.
    Hristova MG
    Med Hypotheses; 2018 Sep; 118():1-5. PubMed ID: 30037593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The link between the metabolic syndrome and cancer.
    Braun S; Bitton-Worms K; LeRoith D
    Int J Biol Sci; 2011; 7(7):1003-15. PubMed ID: 21912508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.
    Garay-Sevilla ME; Gomez-Ojeda A; González I; Luévano-Contreras C; Rojas A
    Mol Cell Biochem; 2021 Mar; 476(3):1555-1573. PubMed ID: 33398664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms.
    Kase NG; Gretz Friedman E; Brodman M; Kang C; Gallagher EJ; LeRoith D
    Am J Obstet Gynecol; 2020 Dec; 223(6):820-833. PubMed ID: 32497614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
    Biadgo B; Abebe M
    Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.
    Giovannucci E
    Am J Clin Nutr; 2007 Sep; 86(3):s836-42. PubMed ID: 18265477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
    Feakins RM
    Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting inflammation in metabolic syndrome.
    Welty FK; Alfaddagh A; Elajami TK
    Transl Res; 2016 Jan; 167(1):257-80. PubMed ID: 26207884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and risk of subsequent colorectal cancer.
    Pais R; Silaghi H; Silaghi AC; Rusu ML; Dumitrascu DL
    World J Gastroenterol; 2009 Nov; 15(41):5141-8. PubMed ID: 19891012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition, metabolic factors and cancer risk.
    Dossus L; Kaaks R
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):551-71. PubMed ID: 18971118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity modulation - the role in carcinogenesis.
    Legakis I; Syrigos K
    Anticancer Agents Med Chem; 2010 Jul; 10(6):481-90. PubMed ID: 20698826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome as a peculiar target for management of prostate cancer patients.
    Conteduca V; Di Lorenzo G; Bozza G; Ardito R; Aieta M
    Clin Genitourin Cancer; 2013 Sep; 11(3):211-20. PubMed ID: 23701880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and cancer: local and systemic mechanisms.
    Iyengar NM; Hudis CA; Dannenberg AJ
    Annu Rev Med; 2015; 66():297-309. PubMed ID: 25587653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
    Halmos T; Suba I
    Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer.
    Bartella V; De Marco P; Malaguarnera R; Belfiore A; Maggiolini M
    Cell Signal; 2012 Aug; 24(8):1515-21. PubMed ID: 22481093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.